NCT04294641 2026-01-23Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host DiseaseNational Institutes of Health Clinical Center (CC)Phase 2 Completed10 enrolled 15 charts
NCT02400476 2022-05-06An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and LoperamidePuma Biotechnology, Inc.Phase 2 Completed563 enrolled 16 charts
NCT00321893 2016-01-25Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung CancerNational Cancer Institute (NCI)Phase 2 Completed225 enrolled 10 charts
NCT00005880 2008-07-24Budesonide in Treating Former and Current Smokers With Bronchial DysplasiaNational Cancer Institute (NCI)Phase 2 Completed